Yaqub B.A. Siddique A., Sulimani R. Effects of methyl-cobalamine on diabetic neuropathy. Clin Neurol Neurosurg. 1992; 94(2):105-111.
Watanabe T., Kaji R., Oka N. et al. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci. 1994;122(2):140-143.
Fonseca V.A., Lavery L.A., Thethi T.K. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med. 2013;126(2):141-9. doi: 10.1016/j.amjmed.2012.06.022..
DOI: 10.1016/j.amjmed.2012.06.022
Trippe B.S., Barrentine L.W., Curole M.V., Tipa E. Nutritional management of patients with diabetic peripheral neuropathy with Metanx: results of a real-world patient experience trial. Curr Med Res Opin. 2016;32(2):219-27. doi: 10.1185/03007995.2015.1103215..
DOI: 10.1185/03007995.2015.1103215
Gareri P., Castagna A., Cotroneo A.M. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-1429. doi: 10.2147/CIA.S87886..
DOI: 10.2147/CIA.S87886
Secades J.J. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol. 2016;63(3):1-73.
Arenth P.M., Russell K.C., Ricker J.H., Zafonte R.D. CDP-choline as a biological supplement during neurorecovery: a focused review. PM R. 2011;3(6 Suppl 1):123-131. doi: 10.1016/j.pmrj.2011.03.012..
DOI: 10.1016/j.pmrj.2011.03.012
Kanat O., Bagdas D., Ozboluk H.Y., Gurun M.S. Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain. J BUON. 2013;18(4):1012-1018.
Ozay R., Bekar A., Kocaeli H. et al. Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats. Surg Neurol. 2007;68(6):615-622. doi: 10.1016/j.surneu.2006.12.054..
DOI: 10.1016/j.surneu.2006.12.054
Gallai V., Mazzotta G., Montesi S. et al. Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study. Acta Neurol Scand. 1992;86(1):3-7.
Palomo-Guerrero M., Cosgaya J.M., Gella A. et al. Uridine-5'-triphosphate partially blocks differentiation signals and favors a more repair state in cultured rat Schwann cells. Neuroscience. 2018;372:255-265. doi: 10.1016/j.neuroscience.2018.01.010..
DOI: 10.1016/j.neuroscience.2018.01.010
Lamarca A., Gella A., Martianez T. et al. Uridine-5-triphosphate promotes in vitro schwannoma cell migration through matrix metalloproteinase-2 activation. PLoS One. 2014;9(6):e98998. doi: 10.1371/journal.pone.0098998..
DOI: 10.1371/journal.pone.0098998
Goldberg H., Mibielli M.A., Nunes C.P. et al. A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias. J Pain Res. 2017;10:397-404. doi: 10.2147/JPR.S123045..
DOI: 10.2147/JPR.S123045
Negrao L., Almeida P., Alcino S. et al. Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies. Pain Manag. 2014;4(3):191-196. doi: 10.2217/pmt.14.10..
DOI: 10.2217/pmt.14.10
Gever J.R., Rothschild S., Henningsen R., Martin R., Hackos D., Panicker S., et al. AF-353, a novel, potent orally bioavailable P2X3/P2X2/3 receptor antagonist. British Journal of Pharmacology. 2010;160:1387-1398.
Ford A.P. In pursuit of P2X3 antagonists: Novel therapeutics for chronic pain and afferent sensitization. Purinergic Signalling. 2012;8:3-26.
Nair A., Simonetti M., Birsa N., Ferrari M.D., van den Maagdenberg A.M., Giniatullin R., et al. Familial hemiplegic migraine Cav2.1 channel mutation R1920 enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain. Molecular Pain. 2010;6:48. doi 10.1186/1744-8069-6-48.
Inoue K., Tsuda M., Tozaki-Saitoh H. Modification of neuropathic pain sensation through microglial ATP receptor. Purinergic Sig. 2007;3:311-316.
Кукушкин М.Л., Решетняк В.К. Пуринерги-ческие механизмы боли и обезболивания. Российский журнал боли. 2019;17(1):51-56. doi: 10.25731/RASP.2019.01.09..
DOI: 10.25731/RASP.2019.01.09
Kretschmar C., Kaumeier S., Haase W. Medica-mentous therapy of alcoholic polyneuropathy. Randomized double-blind study comparing 2 vitamin B preparations and a nucleotide preparation. Fortschr Med. 1996;114:32:439-43.